European Medicines Agency (EMA) Forums This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Re: Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
(Source: BMJ Comments)
Source: BMJ Comments - October 13, 2017 Category: General Medicine Source Type: forums

domperidone and the heart
The European medicines agency has recommended that domperidone doses and indications should be restricted because of cardiovascular risks such as QTc prolongation and VT. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Domperidone-containing_medicines/human_referral_prac_000021.jsp&mid=WC0b01ac05805c516f Personally I don't think I have ever seen such cardiovascular side effects but this may be because domperidone is not prescribed to any extent locally - has anyone else seen such cases? sadian (Source: Doc2Doc BMJ Cardiology)
Source: Doc2Doc BMJ Cardiology - April 27, 2014 Category: Cardiology Authors: sadian Source Type: forums